-
EP4429707
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4429707
| EP4429707 - ANTHRACYCLINE DERIVATIVE LINKER REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.08.2024 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 19.05.2023 | ||
| Former | unknown Status updated on 12.12.2022 | Most recent event Tooltip | 15.08.2024 | Publication in section I.1 EP Bulletin | published on 18.09.2024 [2024/38] | 15.08.2024 | The date on which the examining division becomes responsible, has been established | 15.08.2024 | Request for examination filed | published on 18.09.2024 [2024/38] | Applicant(s) | For all designated states Nerviano Medical Sciences S.r.l. Viale Pasteur, 10 20014 Nerviano (MI) / IT | [2024/38] | Inventor(s) | 01 /
SALSA, Matteo 28043 Bellinzago Novarese (NO) / IT | 02 /
GASPARRI, Fabio 20015 Parabiago (MI) / IT | 03 /
ORSINI, Paolo 20025 Legnano (MI) / IT | 04 /
VALSASINA, Barbara 20131 Milan / IT | [2024/38] | Application number, filing date | 22817113.8 | 04.11.2022 | [2024/38] | WO2022EP80834 | Priority number, date | EP20210207536 | 10.11.2021 Original published format: EP 21207536 | [2024/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023083716 | Date: | 19.05.2023 | Language: | EN | [2023/20] | Type: | A1 Application with search report | No.: | EP4429707 | Date: | 18.09.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.05.2023 takes the place of the publication of the European patent application. | [2024/38] | Search report(s) | International search report - published on: | EP | 19.05.2023 | Classification | IPC: | A61K47/68, A61P35/00, C07D498/14, C07H15/24, C07H15/252 | [2024/38] | CPC: |
A61K47/6809 (EP);
A61P35/00 (EP);
C07D498/14 (EP);
C07H15/24 (EP);
C07H15/252 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/38] | Extension states | BA | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTHRACYCLINDERIVAT-LINKERREAGENZIEN, ANTIKÖRPER-WIRKSTOFF-KONJUGATE UND VERFAHREN | [2024/38] | English: | ANTHRACYCLINE DERIVATIVE LINKER REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | [2024/38] | French: | RÉACTIFS DE LIAISON DE DÉRIVÉ D'ANTHRACYCLINE, CONJUGUÉS ANTICORPS-MÉDICAMENT ET MÉTHODES | [2024/38] | Entry into regional phase | 16.05.2024 | National basic fee paid | 16.05.2024 | Designation fee(s) paid | 16.05.2024 | Examination fee paid | Examination procedure | 16.05.2024 | Amendment by applicant (claims and/or description) | 16.05.2024 | Examination requested [2024/38] | 16.05.2024 | Date on which the examining division has become responsible |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2010009124 (GENENTECH INC [US], et al); | [A]WO2018103739 (XDCEXPLORER SHANGHAI CO LTD [CN]) | by applicant | US4464529 | US4672057 | US4816567 | US5183884 | US5304687 | EP0599274 | US5362852 | US5480968 | US5677171 | WO9802446 | US5821337 | US6054297 | US6165464 | US6407213 | US6719971 | US6800738 | US7521541 | WO2009099741 | WO2010009124 |